Campaign Story

NeuroLink Health was founded to revolutionize the way neurological conditions are detected and managed in India. Today, millions suffer from epilepsy, Parkinson’s, and early-stage dementia—but diagnosis is often delayed due to expensive scans and lack of specialists.

The startup has developed a wearable BCI headband that monitors brainwave activity and syncs with a mobile app. Using AI algorithms, it detects irregularities in neural patterns, alerting users to consult doctors before conditions worsen. It also supports at-home monitoring for patients already undergoing treatment, reducing hospital visits and improving quality of life.

In its pilot trials across hospitals in Bangalore, the device successfully flagged early abnormalities in 68% of patients who otherwise would have gone undiagnosed. Doctors praised its affordability and ease of use, while families appreciated the peace of mind it offered.

But now, NeuroLink Health is desperately short on funds. Hardware manufacturing is expensive, vendors are pressing for upfront payments, and clinical trials require regulatory approvals. Without funding, this life-saving innovation risks never reaching the people who need it most.

With India’s push towards affordable healthcare and MedTech innovation, NeuroLink Health could become a global pioneer if given the resources to survive and scale.